Literature DB >> 17384979

Secondary symptomatic parvovirus B19 infection in a healthy adult.

Julie Kaufmann1, Janet M Buccola, Wendy Stead, Christopher Rowley, Michael Wong, Carol K Bates.   

Abstract

Parvovirus B19 is a common infection in adults and children. There are reports of secondary parvovirus infection in immunocompromised persons, but no reports of symptomatic secondary infection in healthy persons. We describe a healthy 39-year-old woman who presented with fever, rash, and arthralgia. Her symptoms were thought most compatible with parvovirus B19 infection, but she reported prior positive parvovirus antibody 2 years earlier during prenatal care. Tests were therefore also sent for HIV, streptococcal infection, hepatitis C, and Lyme disease. Testing revealed both elevated IgG and IgM antibodies for parvovirus B19; previously, the patient was positive only for IgG. On a subsequent visit she related that a community outbreak of parvovirus developed in her town and church group. We believe this case demonstrates that a symptomatic secondary infection with parvovirus can occur in healthy persons, and that prior positive antibody test does not preclude the development of acute infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384979      PMCID: PMC2219874          DOI: 10.1007/s11606-007-0173-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  7 in total

Review 1.  Parvovirus B19.

Authors:  Neal S Young; Kevin E Brown
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

2.  Secondary parvovirus B19 infection in an immunocompromised child.

Authors:  D Pillay; G Patou; P D Griffiths; L Rees
Journal:  Pediatr Infect Dis J       Date:  1991-08       Impact factor: 2.129

3.  Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.

Authors:  G J Kurtzman; B Cohen; P Meyers; A Amunullah; N S Young
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

Review 4.  Risks associated with human parvovirus B19 infection.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-02-17       Impact factor: 17.586

5.  Chronic bone marrow failure due to persistent B19 parvovirus infection.

Authors:  G J Kurtzman; K Ozawa; B Cohen; G Hanson; R Oseas; N S Young
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

6.  Secondary infection with parvovirus B19 in an HIV-positive patient.

Authors:  J A Bremner; S Beard; B J Cohen; A Alimenti; B Cantiniaux; J Levy
Journal:  AIDS       Date:  1993-08       Impact factor: 4.177

7.  Experimental parvoviral infection in humans.

Authors:  M J Anderson; P G Higgins; L R Davis; J S Willman; S E Jones; I M Kidd; J R Pattison; D A Tyrrell
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

  7 in total
  5 in total

Review 1.  Vaccine Design Informed by Virus-Induced Immunity.

Authors:  Rhiannon R Penkert; Jane S Hankins; Neal S Young; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-05-05       Impact factor: 2.257

Review 2.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19.

Authors:  Nele Goeyvaerts; Niel Hens; Marc Aerts; Philippe Beutels
Journal:  Biostatistics       Date:  2010-09-14       Impact factor: 5.899

4.  Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling.

Authors:  Stéphanie Blaizot; Sereina A Herzog; Steven Abrams; Heidi Theeten; Amber Litzroth; Niel Hens
Journal:  BMC Med Res Methodol       Date:  2019-03-07       Impact factor: 4.615

5.  Aplastic anemia induced by human parvovirus B19 infection in an immunocompetent adult male without prior hematological disorders: A case report.

Authors:  Ayush Mohan Bhattarai; Bishal Dhakal; Pooja Rokaya; Abinash Karki; Shekhar Gurung; Smarika Baral
Journal:  Ann Med Surg (Lond)       Date:  2022-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.